SEP 26, 2017 6:00 AM PDT

WEBINAR: From Research to Routine - developing and delivering multiplexed protein mass spectrometry based tests of clinical utility

Sponsored by: Agilent
  • Professor of Proteomics, Founder, CEO and CSO Atturos Ltd. C/O UCD Conway Institute University College Dublin
      Steve is Professor of Proteomics at University College Dublin, Ireland. A chemist (Imperial College, London) and PhD biochemist (University of Cambridge) by training.

      Through engagement in a series of collaborations and international consortia, his current biomedical proteomics research is directed to the discovery and development of protein biomarkers. On-going projects are focussed on the mass spectrometry based measurement and evaluation of protein biomarkers in oncology and inflammatory disease to progress them to clinical utility. Steve's team are also investigating the mechanisms of disease progression focussing on prostate cancer and psoriatic arthritis.

      Steve is highly energetic and enthusiastic with an innovative, open and inclusive approach to his work. He has given over 200 invited presentations at international events, published over 80 scientific papers, edited and contributed to several books including editing one of the first books on Proteomics that was translated into Chinese and Japanese. Steve has held roles as a committee member in the British Society for Proteome Research (currently vice-President, and the European Proteomics Association. He is the lead organiser of the forthcoming annual world congress of the Human Proteome Organisation (HUPO) that will be held in the national Convention Centre in Dublin from 17-21st September 2017 (

      Recently, Steve founded the UCD spinout company 'Atturos' (Dec 2016) to support the delivery of OCProDx to clinical use. OCProDx is a prostate cancer blood-based biomarker test that has the capability to distinguish patients with organ-confined and non-organ confined disease. The test will help inform men diagnosed with prostate cancer whether they should go on or stay on 'active surveillance' The Atturos team has the expertise and experience to deliver this and other multiplexed protein biomarker tests to market.


    DATE: September 26, 2017
    TIME: 6:00AM PDT

    Despite a few decades of proteomics research and the apparent discovery of multiple protein biomarkers, the number of biomarkers that have been developed to the stage of being used routinely in clinical practice is disappointingly low. So, it's clear that whilst there’s huge interest in the development of new biomarkers and major drivers for this to happen: including the pharmaceutical industry’s need to better stratify patients for effective treatment, as yet biomarker development and delivery is proving very challenging.


    This presentation will cover:

    Start at the end: identifying clinical need

    Protein biomarker discovery

    From candidate protein biomarkers to peptide MRM assays – advantages for biomarker evaluation

    Delivery of robust and routine peptide MRM assays – from sample preparation to test report     


    While further work is still needed, the role of Agilent solutions in each of these key research stages will be shown and will support our conclusion that the pathway for implementation of peptide MRM assays is relatively straightforward and can be implemented in future clinical diagnostics settings.


    See more about how Agilent is helping Stephen Pennington with his research.

    Don’t miss Stephen Pennington’s presentation at MSACL US in January 2018. Follow Agilent’s Clinical Research LinkedIn page for upcoming MSACL announcements.

    View Agilent’s Proven Solutions for Clinical Research & Forensic Toxicology Compendium.

    If you would like to speak with an Agilent Sales Rep or get a quote, let us know!


    For Research Use Only.  Not for use in diagnostic procedures.

    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    AUG 25, 2020 8:00 AM PDT
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    SEP 10, 2020 9:00 AM PDT
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 26, 2017 6:00 AM PDT

    WEBINAR: From Research to Routine - developing and delivering multiplexed protein mass spectrometry based tests of clinical utility

    Sponsored by: Agilent


    Cancer Research

    Molecular Biology





    Cell Biology

    Clinical Diagnostics

    Molecular Diagnostics

    Cancer Diagnostics

    Analytical Chemistry




    Clinical Research


    North America55%



    South America9%



    Registration Source

    Website Visitors100%

    Job Title


    Research Scientist13%




    Facility/Department Manager8%

    Medical Laboratory Technician7%

    Medical Doctor/Specialist6%

    Post Doc6%

    Lab Management5%





    Clinical Laboratory Scientist1%


    Academic Institution12%

    Clinical Laboratory6%


    Biotech Company6%

    Life Science Company6%

    Research Institute4%

    Ambulatory Care4%

    Pharmaceutical Company3%


    Industrial Company2%

    Medical Device Company2%

    Medical School2%

    Independent Laboratories1%

    Non-Profit Organization1%


    Show Resources
    Loading Comments...
    Show Resources
    • See more